secwatch.observer — SEC 8-K summary
======================================

Issuer:     Accustem Sciences Inc. (ACUT)
CIK:        0001850767
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001493152-25-025156
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

AccuStem submits Medicare coverage application for MSC lung cancer test; enters Novitas review
--------------------------------------------------------------------------------

- Submitted local coverage determination to Novitas Solutions for MSC test reimbursement.
- Novitas confirmed application complete and valid; now in review queue for JL region (DC, DE, MD, NJ, PA).
- MSC test analyzes 24 circulating microRNAs in plasma to classify lung nodule risk.
- If approved, could reduce unnecessary biopsies for benign nodules and prioritize high-risk patients.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850767/000149315225025156/0001493152-25-025156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850767/000149315225025156/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-025156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer